ADMS
Adamas Pharmaceuticals

4,785
Mkt Cap
$376.37M
Volume
3.15M
52W High
$9.15
52W Low
$4.02
PE Ratio
-4.85
ADMS Fundamentals
Price
$8.22
Prev Close
$8.16
Open
$8.24
50D MA
$7.00
Beta
1.03
Avg. Volume
2.87M
P/B
-17.38
Loading...
Loading...
News
all
press releases
News Placeholder
Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMS
Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMS Glancy Prongay & Murray...
PR Newswire·1y ago

Latest ADMS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.